{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2006"],"condition":["Colorectal Neoplasms","Cancer"],"disease":["Colorectal Neoplasms","Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2033345"],"location":["United States"],"study_start_month":["10"],"keyword":["Advanced","Oxaliplatin","Colorectal","Metastatic","Leucovorin","Bevacizumab","Fluorouracil","Avastin"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer","description":"To determine efficacy in the delivery of chronomodulated chemotherapy.","dates":{"creation":"2006-10-15"},"accession":"2033345","cross_references":{"ClinicalTrials___gov":["NCT00385021"]}}